Annual Cash & Cash Equivalents
$526.42 M
+$187.27 M+55.22%
December 31, 2023
Summary
- As of February 24, 2025, BCYC annual cash & cash equivalents is $526.42 million, with the most recent change of +$187.27 million (+55.22%) on December 31, 2023.
- During the last 3 years, BCYC annual cash & cash equivalents has risen by +$390.43 million (+287.10%).
- BCYC annual cash & cash equivalents is now at all-time high.
Performance
BCYC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$890.86 M
-$70.50 M-7.33%
September 30, 2024
Summary
- As of February 24, 2025, BCYC quarterly cash and cash equivalents is $890.86 million, with the most recent change of -$70.50 million (-7.33%) on September 30, 2024.
- Over the past year, BCYC quarterly cash and cash equivalents has dropped by -$70.50 million (-7.33%).
- BCYC quarterly cash and cash equivalents is now -7.33% below its all-time high of $961.36 million, reached on June 30, 2024.
Performance
BCYC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BCYC Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +55.2% | -7.3% |
| 3 y3 years | +287.1% | -7.3% |
| 5 y5 years | +730.6% | -7.3% |
BCYC Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +55.2% | -7.3% | +203.2% |
| 5 y | 5-year | at high | +471.5% | -7.3% | +867.1% |
| alltime | all time | at high | +730.6% | -7.3% | +1400.5% |
Bicycle Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $890.86 M(-7.3%) |
| Jun 2024 | - | $961.36 M(+110.4%) |
| Mar 2024 | - | $457.00 M(-13.2%) |
| Dec 2023 | $526.42 M(+55.2%) | $526.42 M(-8.0%) |
| Sep 2023 | - | $572.09 M(+68.0%) |
| Jun 2023 | - | $340.43 M(+15.9%) |
| Mar 2023 | - | $293.81 M(-13.4%) |
| Dec 2022 | $339.15 M(-22.7%) | $339.15 M(-6.2%) |
| Sep 2022 | - | $361.47 M(-3.0%) |
| Jun 2022 | - | $372.77 M(-8.5%) |
| Mar 2022 | - | $407.37 M(-7.1%) |
| Dec 2021 | $438.68 M | $438.68 M(+69.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $259.52 M(+30.6%) |
| Jun 2021 | - | $198.74 M(+1.4%) |
| Mar 2021 | - | $195.90 M(+44.1%) |
| Dec 2020 | $135.99 M(+47.6%) | $135.99 M(-9.2%) |
| Sep 2020 | - | $149.84 M(+54.6%) |
| Jun 2020 | - | $96.91 M(-11.6%) |
| Mar 2020 | - | $109.64 M(+19.0%) |
| Dec 2019 | $92.12 M(+45.3%) | $92.12 M(-4.0%) |
| Sep 2019 | - | $95.95 M(-11.6%) |
| Jun 2019 | - | $108.54 M(+82.8%) |
| Mar 2019 | - | $59.37 M(-6.3%) |
| Dec 2018 | $63.38 M(-6.3%) | $63.38 M |
| Dec 2017 | $67.66 M | - |
FAQ
- What is Bicycle Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Bicycle Therapeutics?
- What is Bicycle Therapeutics annual cash & cash equivalents year-on-year change?
- What is Bicycle Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Bicycle Therapeutics?
- What is Bicycle Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Bicycle Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of BCYC is $526.42 M
What is the all time high annual cash & cash equivalents for Bicycle Therapeutics?
Bicycle Therapeutics all-time high annual cash & cash equivalents is $526.42 M
What is Bicycle Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, BCYC annual cash & cash equivalents has changed by +$187.27 M (+55.22%)
What is Bicycle Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BCYC is $890.86 M
What is the all time high quarterly cash and cash equivalents for Bicycle Therapeutics?
Bicycle Therapeutics all-time high quarterly cash and cash equivalents is $961.36 M
What is Bicycle Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, BCYC quarterly cash and cash equivalents has changed by -$70.50 M (-7.33%)